MYRIAD GENETICS INC
Company Stats
- Market Cap
- $412.2M
- as of Sep 30, 2026
- Enterprise Value
- $387.6M
- Shares Outstanding
- 95.6M
- Free Float
- 98.1%
Income Statement
- Revenue
- $824.5M
- Operating Income
- -$387.2M
- Net Income
- -$365.9M
- EBITDA
- -$367.7M
- Non-cash Impairment
- $319.4M
- Revenue Growth, 3Y
- 6.7%
Balance Sheet
- Cash & Equivalents
- $149.6M
- Total Debt
- $125.0M
- Net Cash
- $24.6M
Returns & Capital
- SBC, 3Y Avg
- $41.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $824.5M | — | — |
| FY2024 | $837.6M | — | — |
| FY2023 | $753.2M | — | — |
| FY2022 | $678.4M | -$151.6M | -22.3% |
| FY2021 | $690.6M | $600,000 | 0.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 25, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back